The evidence is in. Why are IUDs still out?: Family physicians' perceptions of risk and indications

Canadian Family Physician

Volumn 54, Issue 4, 2008, Pages 560-566

  Stubbs, Esther ^a   Schamp, Adrianna ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ARTICLE; CANADA; ECTOPIC PREGNANCY; EMERGENCY CONTRACEPTION; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL INFORMATION; NULLIPARA; PELVIC INFLAMMATORY DISEASE; PERCEPTION; PHYSICIAN; PRACTICE GUIDELINE; RISK ASSESSMENT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UTERINE ARTERY EMBOLIZATION;

EID: 42349084916     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins - Gynecology. Clinical management guidelines for obstetrician- gynecologists. Number 59, January 2005. Intrauterine device. Obstet Gynecol 2005;105(1):223-32.
2. Black A, Francoeur D, Rowe T, Collins J, Miller D, Brown T, et al. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can 2004;26(3):219-96.
3. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49(1):56-72.
4. Milsom I, Andersson K, Jonasson K, Lindstedt G, Rybo G. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. Contraception 1995;52(3):175-9.
5. Larsson G, Milsom I, Jonasson K, Lindstedt G, Rybo G. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception 1993;48(5):471-80.
6. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1997;97(8):690-4.
7. Barrington JW, Bowens-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997;104(5):614-6.
8. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105(6):592-8.
9. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76(2):304-9.
10. Lethaby A, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syt Rev 2005;(4):CD002126.
11. Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivelä A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357(9252):273-7.
12. Lähteenmäki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J, et al. Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998;316(7138):1122-6.
13. Sivin I. Another look at the Dalkon Shield: meta-analysis underscores its problems. Contraception 1993;48(1):1-12.
14. Espey E, Ogburn T. Perpetuating negative attitudes about the intrauterine device: textbooks lag behind the evidence. Contraception 2002;65(6):389-95.
15. Van Lunsen RH, Arnolds HT, van Maris MG. Choices and changes in contraceptive behaviour; the role of information sources. Patient Educ Couns 1994;23(3):197-202.
16. Kooiker CH, Scutchfield FD. Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med 1990;153(3):279-82.
17. Weisberg E, Fraser IS, Goss S. The decline in popularity of the intrauterine device. A survey of general practitioner attitudes and practices in New South Wales. Med J Aust 1994;160(1):19-21.
18. Vos AG, Veldhuis HM, Lagro-Janssen TL. Intrauterine contraception: the role of general practitioners in four Dutch general practices. Contraception 2004;69(4):283-7.